Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
EMDMX-1 by Emyria for Post-Traumatic Stress Disorder (PTSD): Likelihood of Approval
EMDMX-1 is under clinical development by Emyria and currently in Phase II for Post-Traumatic Stress Disorder (PTSD). According to GlobalData,...